cancer therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... tics under development for Renal Cell Carcinoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of......" | 30-Apr-2021 | $2500 | |
Salivary Gland Cancer (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... peutics under development for Salivary Gland Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Actio......" | 30-Apr-2021 | $2000 | |
Bone Sarcoma (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... or Bone Sarcoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete ......" | 30-Apr-2021 | $2000 | |
Papillary Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... ve information on the therapeutics under development for Papillary Renal Cell Carcinoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers t......" | 30-Apr-2021 | $2000 | |
Soft Tissue Sarcoma (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... s under development for Soft Tissue Sarcoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the......" | 30-Apr-2021 | $2500 | |
Squamous Cell Carcinoma (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... therapeutics under development for Squamous Cell Carcinoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacologic......" | 30-Apr-2021 | $2000 | |
Squamous Non-Small Cell Lung Cancer (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... des comprehensive information on the therapeutics under development for Squamous Non-Small Cell Lung Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The ......" | 30-Apr-2021 | $2500 | |
T-Cell Leukemia (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... lopment for T-Cell Leukemia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, i......" | 30-Apr-2021 | $2000 | |
T-Cell Lymphomas (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... evelopment for T-Cell Lymphomas, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutic......" | 30-Apr-2021 | $2000 | |
Transitional Cell Cancer (Urothelial Cell Cancer) (Oncology) - Drugs in Development, 2021By Global Markets Direct "...... e landscape.
The report provides comprehensive information on the therapeutics under development for Transitional Cell Cancer (Urothelial Cell Cancer), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA......" | 30-Apr-2021 | $2000 | |
|